Adicet Bio, Inc.
General ticker "ACET" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $71.8M (TTM average)
Adicet Bio, Inc. follows the US Stock Market performance with the rate: 0.1%.
Estimated limits based on current volatility of 5.7%: low 7.38$, high 8.27$
Factors to consider:
- Total employees count: 152 (+6.3%) as of 2024
- Top business risk factors: Regulatory and compliance, Strategic risks and growth management, Labor/talent shortage/retention, Development risks, Logistics and manufacturing risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.54$, 14.02$]
- 2026-12-31 to 2027-12-31 estimated range: [2.76$, 9.22$]
Financial Metrics affecting the ACET estimates:
- Negative: with PPE of -0.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -174.00 <= 0.07
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 4.37 > -0.65
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share per price, % of 0.07 <= 0.73
Short-term ACET quotes
Long-term ACET plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $152.04MM | $127.61MM | $122.11MM |
| Operating Income | $-152.04MM | $-127.61MM | $-122.11MM |
| Non-Operating Income | $9.38MM | $10.49MM | $5.31MM |
| Interest Expense | $0.03MM | $0.00MM | $0.04MM |
| R&D Expense | $106.04MM | $99.32MM | $99.13MM |
| Income(Loss) | $-142.66MM | $-117.12MM | $-116.80MM |
| Taxes | $0.00MM | $0.02MM | $0.00MM |
| Other Income(Loss) | $0.00MM | $0.02MM | $0.00MM |
| Profit(Loss)* | $-142.66MM | $-117.12MM | $-116.80MM |
| Stockholders Equity | $170.18MM | $186.61MM | $159.21MM |
| Assets | $207.29MM | $220.22MM | $192.35MM |
| Operating Cash Flow | $-93.72MM | $-92.38MM | $-95.25MM |
| Capital expenditure | $4.46MM | $1.12MM | $1.74MM |
| Investing Cash Flow | $-4.46MM | $-119.24MM | $2.39MM |
| Financing Cash Flow | $0.24MM | $111.31MM | $75.25MM |
| Earnings Per Share** | $-53.03 | $-21.33 | $-16.95 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.